Related Experiment Videos
Leukemic relapse 5 1/2 years after allogeneic bone marrow transplantation
Blood
|August 1, 1978
Summary
This case study highlights a rare late relapse of acute myelogenous leukemia (AML) after successful bone marrow transplant. It emphasizes the importance of long-term patient monitoring post-transplant.
Area of Science:
- Hematology
- Oncology
- Transplantation Medicine
Background:
- Acute myelogenous leukemia (AML) is a serious hematologic malignancy.
- Allogeneic bone marrow transplantation is a potential curative therapy for AML.
- Long-term complications and relapse patterns after transplantation require further investigation.